Mounjaro®
Starting from £179.99/mo
Start journey Learn morePrivate weight loss injections in Northern Ireland — Mounjaro and Wegovy — are priced per monthly pen, and any legitimate price covers a clinical assessment alongside the medicine itself. Typical private market prices since the Eli Lilly list-price rise in September 2025 run roughly £149–£375 per month, varying by medicine and dose. These are prescription-only medicines: a qualified prescriber must assess your suitability before any is dispensed, wherever in the UK you access them. What headline prices say, and what they leave out, is where the real comparison starts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks from patients in Northern Ireland goes something like this: "I've seen it for £X elsewhere, why does your price look different?" It is a fair question, and it deserves a direct answer.
The biggest misconception around weight loss injection pricing is that the number displayed on a website represents the total cost of treatment. It rarely does. Many providers separate the consultation fee (sometimes £20–£50), the prescription fee, delivery, and any follow-up or aftercare into distinct charges. By the time those are added, the final figure can sit well above the headline. Some providers also charge extra for dose increases, which are a normal part of treatment as the prescriber moves you through the licensed titration schedule.
The medicines themselves (Mounjaro (tirzepatide) and Wegovy (semaglutide)) are licensed UK weight loss injections dispensed under a prescription. Since Eli Lilly raised its UK list prices from 1 September 2025, the market range for private treatment has shifted noticeably; reported private prices now run roughly £149–£375 per month across doses and providers. That context, widely reported at the time of the Lilly announcement, is useful background, but those figures reflect the medicine cost only and tell you nothing about what else is, or is not, bundled in.
Worth checking: before comparing any two prices, ask what each one actually covers.
Geography matters less than you might expect. Because these are prescription medicines dispensed by registered pharmacies and delivered nationwide, someone in Belfast or Derry faces the same regulatory framework as someone in Bristol. What changes with provider choice is the clinical infrastructure around the medicine, and that is what the price should reflect.
Legitimate private treatment requires identity verification, a thorough clinical assessment, a prescription from a qualified prescriber, and ongoing review. The NHS pricing picture is different again: Mounjaro is being phased onto the NHS through a staged rollout under NICE technology appraisal TA1026, but eligibility is tightly defined and access varies across Northern Ireland, where health commissioning decisions differ from NHS England. Most people who search for private pricing do so because NHS access is not yet open to them, or because they would rather not wait.
When you look at the average cost of weight loss injections in the UK private market, the spread is wide. The lower end of that range sometimes reflects a stripped-back model: no aftercare, no prescriber continuity, delivery costs added separately. The higher end does not automatically mean better clinical care either. The useful question is what a given price buys clinically, not where it sits on a league table.
If you are considering a payment spread, some people look at options like weight loss injections with Klarna pricing, it is worth understanding exactly what any finance arrangement includes before committing.
Mounjaro and Wegovy are Prescription-Only Medicines. That classification exists because they require clinical oversight, they are not consumer goods where the only variable is price. The MHRA has warned publicly about counterfeit weight loss pens sold online, including a raid on an illicit manufacturing site producing fake tirzepatide pens in October 2025 and the seizure of around 20 million doses of illegally traded weight loss medicines worth approximately £45 million. Sellers offering these medicines without a clinical assessment are a regulatory red flag, and the medicines they supply carry real physical risk.
The right test for a private weight loss injection provider is whether they are registered with the GPhC (verifiable at the GPhC pharmacy register), whether a real prescriber (not an automated system) reviews your consultation, and whether clinical support continues after your first pen arrives. You can read more about how to think about cost alongside safety when comparing providers.
At nume, we are not the cheapest option and we have no interest in being. One transparent price covers the consultation, the prescription, the medicine, delivery and aftercare, nothing is added at checkout, and there are no subscriptions. Our clinical team reviews every consultation personally, and every repeat order goes through the same clinical check. That is the standard we hold ourselves to, because a small saving on a prescription medicine is not worth the trade-off if the clinical infrastructure behind it is thin. If you want to understand the full weight loss injection price picture before starting, our free consultation is the place to begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.